|
|
|
|
|
|
|
4 Reasons For The Rise In Blister Packaging | Article | By Yves Massicotte, Ropack Pharma Solutions | Here are the factors that are driving blister to the forefront of pharmaceutical packaging, and at an even faster rate than its current growth. |
|
|
|
|
By Louis Garguilo, chief editor, Outsourced Pharma | "Be prepared. Structured. Work in a systematic fashion towards your CDMO selection." That's a, shall we say, rather non-psychedelic paraphrasing from Anthony Grenier of Reunion Neuroscience, a biotech pursuing the development of novel, synthetic psychedelic molecules. Here's more of his thoughts on CDMO selection. | |
|
|
|
INDUSTRY INSIGHTS CONTINUED |
|
|
Enabled Form Selection For Oral Drug Products | Webinar | Lonza | Review the role of solid form screening and PBPK modeling to enable accelerated timelines desirable in early-phase drug development. Explore formulation maps for ASDs and key criteria for salt screening. |
|
|
|
Integrating Phase-Appropriate Quality Standards | Application Note | MilliporeSigma | Partnering with an experienced CDMO can provide valuable expertise in defining expectations and requirements, while efficiently managing accelerated product development timelines. |
|
|
|
Comprehensive Regulatory Support | Douglas CDMO | Consider our expertise across a wide range of global markets. Our experience in securing regulatory approvals and navigating market challenges positions us as a trusted partner. |
|
|
Wet Nanomilling And Vial Filling | Altasciences | Nanomilling revolutionizes drug delivery by reducing particle size to enhance solubility, bioavailability, and therapeutic efficacy, addressing the challenges of poorly water-soluble APIs. |
|
|
Unlocking A Reliable Supply Chain | Pfizer CentreOne | With end-to-end solutions, proven experience in complex formulations, and a commitment to operational excellence, we help you navigate challenges, mitigate risks, and deliver high-quality therapies efficiently. |
|
|
|
|
|
| Join Outsourced Pharma Live on June 11th at 2pm ET for a virtual panel discussion on the specific challenges of biologics development that must drive CDMOs to embrace more flexible approaches. Registration is free thanks to the support of Curia. |
|
|
OUTSOURCED PHARMA CAPACITY UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
| Connect With Outsourced Pharma: |
|
|
|
